The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of ziv-aflibercept (Z) + FOLFIRI in Japanese patients (pts) with metastatic colorectal cancer (mCRC).
 
Taroh Satoh
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Yakult Honsha (Inst)
 
Tadamichi Denda
Research Funding - Sanofi (Inst)
 
Tetsuya Hamaguchi
Honoraria - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - NanoCarrier
Research Funding - Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); MSD (Inst); NanoCarrier (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Teijin Pharma (Inst)
 
Naotoshi Sugimoto
Speakers' Bureau - Chugai Pharma; Lilly
Research Funding - Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Lilly; MSD; Ono Pharmaceutical; Sanofi (Inst); Taiho Pharmaceutical
 
Takashi Ura
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda
Research Funding - Sanofi (Inst)
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb Japan (Inst); Sanofi (Inst)
 
Hirofumi Fujii
Research Funding - Sanofi (Inst)
 
Takeshi Kajiwara
Research Funding - Sanofi (Inst)
 
Takako Eguchi Nakajima
Honoraria - Chugai Pharma; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Lilly; Taiho Pharmaceutical
Research Funding - Amgen Astellas BioPharma; AstraZeneca; Chugai Pharma; Merck Serono; Ono Pharmaceutical; Otsuka; Quintiles; Sanofi; Taiho Pharmaceutical; Takeda
 
Shin Takahashi
Speakers' Bureau - Asahi Kasei; Chugai Pharma; Daiichi Sankyo; Medicon; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Novartis; Taiho Pharmaceutical
Research Funding - Sanofi (Inst)
 
Satoshi Otsu
Research Funding - Sanofi (Inst)
 
Yoshito Komatsu
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; Lilly; Sanofi (Inst)
 
Toru Sasaki
Employment - Sanofi
 
Yoshinori Sunaga
Employment - Sanofi
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst)